The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical effectiveness of adjuvant chemotherapy (AC) with or without oxaliplatin following neoadjuvant chemoradiotherapy (nCRT) in stage II rectal cancer (RC).
 
Jonathan M. Loree
No Relationships to Disclose
 
Hagen F. Kennecke
No Relationships to Disclose
 
Erin Diana Powell
No Relationships to Disclose
 
Rachel Anne Goodwin
No Relationships to Disclose
 
Patricia A. Tang
No Relationships to Disclose
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
 
Julie A. Price Hiller
No Relationships to Disclose
 
Jose Gerard Monzon
Speakers' Bureau - Bristol-Myers Squibb; Merck; Roche
 
Michael M. Vickers
No Relationships to Disclose
 
Winson Y. Cheung
No Relationships to Disclose